SARS-CoV-2 Antibody Assay

$450.00

In Stock & Ready to Ship

This is an Antibody Serologic Assay (SCSA) for SARS-CoV-2. 

 

This test has not been reviewed by the FDA.

 

The SARS-CoV-2 Antibody rapid test is a lateral flow chromatographic immunoassay for the qualitative detection of IgM/IgG anti-SARS CoV-2 antibody which may be found in samples such as serum, plasma, whole blood or cell culture media. This product is suitable for screening for the presence of SARS-CoV-2 reactive antibody in a Research Use Only Fashion.

Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.

Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.

Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.

Share:
Clear
Compare

For Research Use Only. Not for use in Diagnostic Procedures.


Both IgM and IgG are immunoglobulin which are produced by the immune system to provide protection against SARS-CoV-2. Some patients with negative results in nucleic acid test show positive in IgM test, indicating that the IgG / IgM detection is one of the effective methods for the analysis of SARS CoV-2.  The level of IgM antibody begins to rise after 1 week after the initial infection, while the IgG appears later than IgM (usually in 14 days after infection) and can last for 6 months or even several years, which means that the IgG serves as an indicator of previous infection. Suspected patients that are infected by SARS CoV-2 can be rapidly identified by simultaneous monitoring of IgM and IgG. During the outbreak period of 2003-SARS and the 2016-Zika, IgM / IgG antibody detection was used as one of the recommended testing methods.

 

Highly stable and uniform nanoparticles.  The quality and performance of a conjugate is critical to successful lateral flow test manufacturing.  Our products are produced in a state-of-the-art manufacturing facility that enable rapid turnaround times while ensuring batch to batch consistency and reliability.

For additional sizes not listed please email: sales@attogene.com

You may also like…

10nm Colloidal Gold for Lateral Flow

$500.00

Specifications 1OD 10nm Gold (1L)

• Number of particles/mL 2.5- 8.6 x 1012
• Gold Concentration (mg/mL) 5.7- 6.0 x 10-2
• Molar Concentration (moles/liter) 0.4-1.4 x 10-8
• Particle Diameter 10 nm /- 1.5

Coronavirus (COVID-19, Strain 2019-nCoV)

$1,321.04

Product Features

  • • Exceptional value for money
  • • Rapid detection of 2019-nCoV
  • • Positive copy number standard curve for quantification
  • • Highly specific detection profile
  • • High priming efficiency
  • • Broad dynamic detection range (>6 logs)
  • • Sensitive to < 100 copies of target
  • • Accurate controls to confirm findings

 

30nm Colloidal Gold for Lateral Flow

$500.00

Specifications 1OD 30nm Gold (1L)

• Number of particles/mL 1.3-2 x 1011
• Gold Concentration (mg/mL) 4.2-4.7 x 10-2
• Molar Concentration (moles/liter) 2.2-3.3 x 10-10
• Particle Diameter 30 nm /-1.5

Streptavidin Colloidal Gold for Lateral Flow

$350.00

Highly stable and uniform Strepavadin 40 nm gold nanoparticles.  The quality and performance of a conjugate is critical to successful lateral flow test manufacturing.  Our products are produced in a state-of-the-art manufacturing facility that enable rapid turnaround times while ensuring batch to batch consistency and reliability.

40nm Colloidal Gold for Lateral Flow

$500.00

Specifications 1OD 40nm Gold (1L)

Number of particles/mL 5.2-7.2 x 1010
Gold Concentration (mg/mL) 3.7-4.2 x 10-2
Molar Concentration (moles/liter) 8-12 x 10-11
Particle Diameter 40 nm /- 1.5